Rituximab as first line treatment for MALT lymphoma of extraocular muscles

被引:0
作者
Leonidas Benetatos
Vasiliki Alymara
Ioannis Asproudis
Konstantinos L. Bourantas
机构
[1] University Hospital of Ioannina,Department of Hematology
[2] University Hospital of Ioannina,Department of Ophthalmology
来源
Annals of Hematology | 2006年 / 85卷
关键词
Lymphoma; Malt Lymphoma; Extraocular Muscle; Marginal Zone Lymphoma; Bone Marrow Infiltration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:625 / 626
页数:1
相关论文
共 34 条
[1]  
Lee JL(2005)Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa Ann Hematol 84 13-18
[2]  
Kim MK(2005)Tolerability and safety of rituximab (MabThera) Cancer Treat Rev 31 456-473
[3]  
Lee KH(2004)Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva Eur J Haematol 73 258-262
[4]  
Hyun MS(2004)Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab Leuk Lymphoma 45 1275-1278
[5]  
Chung HS(2005)Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland—a case report In Vivo 19 1105-1109
[6]  
Kim DS(2006)Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci Blood 107 467-472
[7]  
Shin SO(undefined)undefined undefined undefined undefined-undefined
[8]  
Cho HS(undefined)undefined undefined undefined undefined-undefined
[9]  
Bae SH(undefined)undefined undefined undefined undefined-undefined
[10]  
Ryoo HM(undefined)undefined undefined undefined undefined-undefined